Journal article
Cooling down VITT with IVIG
Blood, Vol.138(11), pp.921-922
09/16/2021
DOI: 10.1182/blood.2021012819
PMCID: PMC8444694
PMID: 34529019
Abstract
In this issue of Blood, Uzun et al report additional clinical experience using IV immunoglobulin (IVIG) for the treatment of COVID-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).
Details
- Title: Subtitle
- Cooling down VITT with IVIG
- Creators
- Steven R. Lentz - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Blood, Vol.138(11), pp.921-922
- Publisher
- Amer Soc Hematology
- DOI
- 10.1182/blood.2021012819
- PMID
- 34529019
- PMCID
- PMC8444694
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Number of pages
- 3
- Language
- English
- Date published
- 09/16/2021
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984359954002771
Metrics
8 Record Views